Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Elizabeth McFarland

Concepts (381)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV-1
26
2025
862
2.890
 Why?
HIV Infections
48
2025
2822
2.870
 Why?
Respiratory Syncytial Virus Vaccines
6
2022
35
2.370
 Why?
Respiratory Syncytial Virus Infections
6
2022
127
2.170
 Why?
Respiratory Syncytial Virus, Human
6
2022
75
2.160
 Why?
Infectious Disease Transmission, Vertical
18
2025
180
2.130
 Why?
HIV Antibodies
12
2025
62
2.050
 Why?
Anti-Retroviral Agents
12
2023
235
1.750
 Why?
Viral Proteins
3
2020
346
1.570
 Why?
Antibodies, Viral
8
2022
620
1.130
 Why?
Antibodies, Neutralizing
8
2025
282
1.100
 Why?
Colonography, Computed Tomographic
3
2024
8
0.980
 Why?
Antibodies, Monoclonal
6
2025
1417
0.880
 Why?
Anti-HIV Agents
11
2025
773
0.880
 Why?
AIDS Vaccines
8
2018
52
0.860
 Why?
Pregnancy Complications, Infectious
8
2016
387
0.770
 Why?
Gene Deletion
2
2020
393
0.730
 Why?
Breast Feeding
4
2025
439
0.650
 Why?
Atazanavir Sulfate
2
2017
41
0.640
 Why?
HIV Protease Inhibitors
2
2017
69
0.630
 Why?
Ritonavir
2
2017
73
0.620
 Why?
Vaccination
6
2020
1387
0.580
 Why?
Vaccines, Attenuated
6
2022
129
0.580
 Why?
HIV Envelope Protein gp120
6
2017
60
0.580
 Why?
Infant, Newborn
23
2025
6043
0.580
 Why?
Incidental Findings
1
2018
87
0.550
 Why?
Radiation Dosage
1
2018
172
0.520
 Why?
Infant
31
2025
9408
0.510
 Why?
Nelfinavir
1
2016
9
0.510
 Why?
Lopinavir
1
2016
30
0.500
 Why?
Syncope
1
2016
52
0.500
 Why?
Bradycardia
1
2016
54
0.500
 Why?
Patient Dropouts
1
2016
67
0.490
 Why?
Lyme Disease
1
2016
58
0.480
 Why?
Health Resources
1
2016
122
0.470
 Why?
Infant, Newborn, Diseases
1
2016
113
0.450
 Why?
HIV
5
2014
232
0.420
 Why?
Patient Compliance
2
2018
586
0.400
 Why?
Immunogenicity, Vaccine
4
2021
30
0.390
 Why?
Referral and Consultation
1
2018
779
0.380
 Why?
Child
37
2025
21896
0.380
 Why?
Humans
74
2025
136899
0.370
 Why?
T-Lymphocytes, Cytotoxic
4
2005
173
0.360
 Why?
CD4-Positive T-Lymphocytes
2
2017
1092
0.360
 Why?
Virus Replication
4
2020
477
0.350
 Why?
Female
48
2025
72703
0.340
 Why?
Lymphocyte Activation
5
2017
1150
0.310
 Why?
Male
39
2025
67308
0.300
 Why?
Adolescent
27
2025
21402
0.290
 Why?
Viral Load
9
2017
461
0.280
 Why?
HIV Seropositivity
2
2023
124
0.280
 Why?
Bone Density
2
2025
486
0.270
 Why?
Double-Blind Method
3
2020
1980
0.260
 Why?
RNA, Viral
8
2023
651
0.260
 Why?
Antibodies, Bacterial
2
2018
146
0.250
 Why?
Antiretroviral Therapy, Highly Active
6
2017
272
0.240
 Why?
Dyslipidemias
2
2017
177
0.240
 Why?
Bone Development
1
2025
54
0.230
 Why?
Immunoenzyme Techniques
1
2005
219
0.230
 Why?
Immunoglobulin G
3
2022
886
0.220
 Why?
Viremia
3
2011
135
0.220
 Why?
Diverticulum
1
2024
12
0.220
 Why?
Gene Products, gag
2
1994
36
0.210
 Why?
Mammography
1
2025
151
0.210
 Why?
Child, Preschool
21
2022
11013
0.210
 Why?
Young Adult
12
2021
13157
0.200
 Why?
Squalene
3
2017
7
0.200
 Why?
Pregnancy
11
2023
6715
0.200
 Why?
Complementarity Determining Regions
1
2002
51
0.200
 Why?
Drug Resistance, Viral
2
2016
115
0.190
 Why?
CD4 Lymphocyte Count
4
2017
270
0.190
 Why?
Half-Life
1
2021
166
0.180
 Why?
Growth Differentiation Factor 15
1
2021
41
0.180
 Why?
Mitochondrial Diseases
1
2021
92
0.180
 Why?
Immunization Schedule
2
2018
200
0.180
 Why?
Fibroblast Growth Factors
1
2021
171
0.170
 Why?
Drug Therapy, Combination
4
2017
1060
0.170
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
337
0.170
 Why?
T-Lymphocytes
2
2009
1996
0.170
 Why?
RNA, Small Untranslated
1
2020
16
0.170
 Why?
env Gene Products, Human Immunodeficiency Virus
2
2017
16
0.170
 Why?
Hydrophobic and Hydrophilic Interactions
1
2020
191
0.160
 Why?
Cytokines
2
2021
2078
0.160
 Why?
Body Temperature
1
2020
221
0.150
 Why?
Point Mutation
1
2020
234
0.150
 Why?
Insulin Resistance
3
2019
1187
0.150
 Why?
Haemophilus Vaccines
2
2018
30
0.150
 Why?
Immunocompromised Host
2
2000
203
0.150
 Why?
Immunologic Memory
2
2021
368
0.150
 Why?
Metabolic Syndrome
1
2021
348
0.140
 Why?
Darunavir
1
2017
18
0.140
 Why?
Interleukin-12
1
1998
121
0.140
 Why?
CD8-Positive T-Lymphocytes
2
2011
916
0.140
 Why?
Mycobacterium Infections, Nontuberculous
2
2012
355
0.140
 Why?
Therapeutic Equipoise
1
2017
2
0.140
 Why?
Dose-Response Relationship, Drug
1
2021
2066
0.140
 Why?
Interferon-gamma
5
2012
790
0.130
 Why?
Lymphopoiesis
1
2017
26
0.130
 Why?
Uganda
1
2017
72
0.130
 Why?
Immunoglobulin A
2
2017
208
0.130
 Why?
Antibody Formation
1
2018
299
0.130
 Why?
Receptors, CCR5
1
2017
59
0.130
 Why?
CD4-CD8 Ratio
1
2016
22
0.130
 Why?
High-Throughput Screening Assays
1
2018
159
0.130
 Why?
HIV-Associated Lipodystrophy Syndrome
1
2016
12
0.130
 Why?
Adoption
1
2016
32
0.130
 Why?
Mothers
3
2017
752
0.120
 Why?
Cohort Studies
8
2025
5711
0.120
 Why?
Virus Latency
1
2016
85
0.120
 Why?
Continuity of Patient Care
1
2018
279
0.120
 Why?
Chickenpox Vaccine
1
2015
71
0.120
 Why?
Early Diagnosis
1
2016
243
0.120
 Why?
Zimbabwe
2
2025
55
0.120
 Why?
Body Height
2
2017
201
0.120
 Why?
Gene Products, env
1
1994
6
0.120
 Why?
Adult
15
2023
37595
0.120
 Why?
Disease Susceptibility
1
2017
344
0.120
 Why?
Haemophilus influenzae type b
1
2014
12
0.110
 Why?
Chickenpox
1
2015
81
0.110
 Why?
Bacterial Capsules
1
2014
30
0.110
 Why?
Antibody Affinity
1
2014
60
0.110
 Why?
Acquired Immunodeficiency Syndrome
2
2000
233
0.110
 Why?
Cote d'Ivoire
2
2025
9
0.110
 Why?
South Africa
2
2025
219
0.110
 Why?
Parotitis
1
2014
6
0.110
 Why?
Vaccines, Synthetic
4
2005
126
0.110
 Why?
Developing Countries
1
2016
305
0.110
 Why?
Puberty, Delayed
1
2013
5
0.110
 Why?
Cytotoxicity, Immunologic
3
2002
225
0.110
 Why?
Intestines
1
2017
356
0.110
 Why?
Leukocytes, Mononuclear
4
2013
557
0.110
 Why?
RNA-Directed DNA Polymerase
1
1993
34
0.100
 Why?
Mycobacterium chelonae
1
1993
8
0.100
 Why?
Vaccines
1
2018
408
0.100
 Why?
Retrospective Studies
8
2023
15514
0.100
 Why?
Lipids
1
2017
664
0.100
 Why?
Patient Selection
1
2017
690
0.100
 Why?
Lamivudine
3
2023
62
0.100
 Why?
Colorectal Neoplasms
1
2020
797
0.100
 Why?
Breast Neoplasms
1
2025
2243
0.100
 Why?
Cell Movement
1
2017
971
0.100
 Why?
Mitochondria
2
2021
938
0.100
 Why?
Child Development
1
2017
474
0.090
 Why?
Pediatric Obesity
1
2019
588
0.090
 Why?
Clinical Trials as Topic
1
2017
1037
0.090
 Why?
STAT1 Transcription Factor
1
2012
75
0.090
 Why?
Cardiovascular Diseases
2
2016
2110
0.090
 Why?
Body Fat Distribution
1
2011
49
0.090
 Why?
Body Weight
2
2017
973
0.090
 Why?
Polysorbates
3
2017
41
0.090
 Why?
Prospective Studies
4
2017
7543
0.090
 Why?
Mycobacterium avium Complex
1
2012
88
0.090
 Why?
Epitopes
2
2022
479
0.090
 Why?
Cost-Benefit Analysis
2
2025
592
0.090
 Why?
United States
9
2023
14595
0.090
 Why?
Research Design
1
2017
1108
0.080
 Why?
Biomedical Research
1
2017
688
0.080
 Why?
Interleukin-2
2
2003
455
0.080
 Why?
Respiratory Tract Infections
1
2014
395
0.080
 Why?
Exercise
1
2021
2015
0.080
 Why?
Prenatal Exposure Delayed Effects
1
2016
606
0.080
 Why?
Freezing
1
2009
91
0.080
 Why?
Absorptiometry, Photon
2
2025
251
0.080
 Why?
Blood
1
2009
106
0.080
 Why?
Algorithms
1
2016
1695
0.070
 Why?
Staff Development
1
2009
55
0.070
 Why?
Phenotype
1
2017
3201
0.070
 Why?
Age Factors
4
2019
3290
0.070
 Why?
T-Lymphocyte Subsets
2
2002
425
0.070
 Why?
Lymphocyte Subsets
2
2009
87
0.070
 Why?
Longitudinal Studies
3
2025
2844
0.070
 Why?
Biomarkers
4
2021
4148
0.070
 Why?
Specimen Handling
1
2009
178
0.070
 Why?
Enzyme-Linked Immunosorbent Assay
2
2021
849
0.070
 Why?
Withholding Treatment
1
2008
72
0.070
 Why?
Enterovirus A, Human
1
2007
12
0.070
 Why?
Faculty
1
2009
143
0.070
 Why?
Adipose Tissue
1
2011
624
0.070
 Why?
Central Nervous System Viral Diseases
1
2007
76
0.060
 Why?
Polymerase Chain Reaction
4
2011
1061
0.060
 Why?
Academic Medical Centers
1
2009
494
0.060
 Why?
DNA, Viral
2
2000
359
0.060
 Why?
Flow Cytometry
3
2009
1185
0.060
 Why?
False Negative Reactions
1
2025
54
0.060
 Why?
Isoantigens
1
1984
15
0.060
 Why?
Cell Line
3
2012
2847
0.060
 Why?
Medical Audit
1
2025
76
0.060
 Why?
Enterovirus Infections
1
2007
175
0.060
 Why?
C-Reactive Protein
2
2021
409
0.060
 Why?
Immunity, Cellular
1
2006
267
0.060
 Why?
Colorado
3
2023
4491
0.060
 Why?
Disease Outbreaks
1
2007
374
0.060
 Why?
Linear Models
2
2020
850
0.050
 Why?
Follow-Up Studies
3
2021
5126
0.050
 Why?
Confusion
1
2024
28
0.050
 Why?
Comorbidity
2
2021
1611
0.050
 Why?
Sequence Analysis, DNA
2
2007
811
0.050
 Why?
Thymus Gland
1
1984
312
0.050
 Why?
Tablets
1
2023
35
0.050
 Why?
Constriction, Pathologic
1
2024
242
0.050
 Why?
Risk Factors
4
2021
10313
0.050
 Why?
Regression Analysis
2
2021
1026
0.050
 Why?
Respiratory Syncytial Viruses
1
2022
52
0.050
 Why?
Genes, T-Cell Receptor beta
1
2002
22
0.050
 Why?
Immunophenotyping
2
1994
318
0.050
 Why?
Zidovudine
2
2015
78
0.050
 Why?
Clone Cells
1
2002
266
0.050
 Why?
Dose-Response Relationship, Immunologic
1
2001
82
0.050
 Why?
Cough
1
2022
121
0.050
 Why?
Emtricitabine
1
2023
173
0.050
 Why?
Vaccines, Subunit
1
2001
49
0.050
 Why?
Pyridones
1
2023
165
0.040
 Why?
Tenofovir
1
2023
239
0.040
 Why?
Clinical Trials, Phase I as Topic
1
2021
51
0.040
 Why?
Public Health Surveillance
1
2021
77
0.040
 Why?
Lung
1
2014
4046
0.040
 Why?
Ganciclovir
1
2000
53
0.040
 Why?
Adjuvants, Immunologic
2
2017
226
0.040
 Why?
Computer Simulation
1
2005
984
0.040
 Why?
Africa
1
2020
109
0.040
 Why?
Injections, Subcutaneous
1
2020
154
0.040
 Why?
Diagnostic Tests, Routine
1
2021
109
0.040
 Why?
Symptom Assessment
1
2021
126
0.040
 Why?
Cross-Sectional Studies
3
2021
5398
0.040
 Why?
Sex Factors
2
2019
2067
0.040
 Why?
HIV Seronegativity
1
2019
28
0.040
 Why?
HLA-D Antigens
1
1999
34
0.040
 Why?
Risk
1
2021
905
0.040
 Why?
Case-Control Studies
2
2019
3528
0.040
 Why?
Prevalence
2
2016
2709
0.040
 Why?
Cytomegalovirus Infections
1
2000
194
0.040
 Why?
Lymphocyte Culture Test, Mixed
1
1998
50
0.040
 Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2018
25
0.040
 Why?
Cytotoxicity Tests, Immunologic
1
1998
41
0.040
 Why?
Vaccines, Combined
1
2018
48
0.040
 Why?
Cholesterol, HDL
1
2019
205
0.040
 Why?
Hospitals
1
2023
678
0.040
 Why?
Poliovirus Vaccine, Inactivated
1
2018
28
0.040
 Why?
Hepatitis B Vaccines
1
2018
47
0.040
 Why?
Amino Acid Sequence
1
2002
2143
0.040
 Why?
Odds Ratio
1
2021
1063
0.040
 Why?
Colon
1
2020
270
0.040
 Why?
Mutation
3
2018
3948
0.040
 Why?
Drug Resistance, Microbial
2
2000
71
0.040
 Why?
Nutrition Surveys
1
2019
267
0.040
 Why?
Molecular Sequence Data
1
2002
2901
0.030
 Why?
Case Management
1
2018
65
0.030
 Why?
Antigens, Viral
1
1998
180
0.030
 Why?
Cholesterol
1
2019
412
0.030
 Why?
Cholesterol, LDL
1
2019
362
0.030
 Why?
Epitopes, T-Lymphocyte
1
1998
187
0.030
 Why?
Immune Tolerance
1
1999
362
0.030
 Why?
Treatment Adherence and Compliance
1
2017
26
0.030
 Why?
Triglycerides
1
2019
524
0.030
 Why?
Disease Management
1
2021
624
0.030
 Why?
Reproducibility of Results
1
2005
3282
0.030
 Why?
Lymphocyte Count
2
2009
150
0.030
 Why?
Cell Division
1
1998
795
0.030
 Why?
Uncertainty
1
2017
125
0.030
 Why?
Treatment Failure
1
2017
353
0.030
 Why?
Multicenter Studies as Topic
1
2017
303
0.030
 Why?
Nevirapine
1
2015
17
0.030
 Why?
Seroepidemiologic Studies
1
2015
163
0.030
 Why?
Time-to-Treatment
1
2017
200
0.030
 Why?
Maternal Exposure
1
2017
188
0.030
 Why?
Malnutrition
1
2016
82
0.030
 Why?
Genes, pol
1
1994
7
0.030
 Why?
Patient Outcome Assessment
1
2016
132
0.030
 Why?
Randomized Controlled Trials as Topic
1
2021
1460
0.030
 Why?
Antiviral Agents
1
2000
739
0.030
 Why?
Coinfection
1
2016
135
0.030
 Why?
Vaccines, Conjugate
1
2014
65
0.030
 Why?
Neutropenia
1
2015
146
0.030
 Why?
Treatment Outcome
2
2021
10768
0.030
 Why?
Counseling
1
2018
392
0.030
 Why?
Sexual and Gender Minorities
1
2018
210
0.030
 Why?
Cells, Cultured
2
2008
4204
0.030
 Why?
Global Health
1
2017
384
0.030
 Why?
Anemia
1
2015
171
0.030
 Why?
Maternal-Fetal Exchange
1
2014
165
0.030
 Why?
Electron Transport Complex IV
1
2013
59
0.030
 Why?
Electron Transport Complex I
1
2013
41
0.030
 Why?
Tuberculosis, Cutaneous
1
1993
3
0.030
 Why?
Thrombocytopenia
1
2015
198
0.030
 Why?
HIV Reverse Transcriptase
1
1993
31
0.030
 Why?
CD8 Antigens
1
1993
75
0.030
 Why?
Radiography, Thoracic
1
2014
168
0.030
 Why?
Severity of Illness Index
1
2021
2833
0.030
 Why?
Medication Adherence
1
2017
514
0.020
 Why?
CD3 Complex
1
1993
106
0.020
 Why?
Drug Administration Schedule
2
2008
784
0.020
 Why?
Oxidative Phosphorylation
1
2013
193
0.020
 Why?
Lymphocytes
1
1994
393
0.020
 Why?
Blood Pressure
1
2019
1774
0.020
 Why?
DNA, Mitochondrial
1
2013
201
0.020
 Why?
P-Selectin
1
2011
28
0.020
 Why?
E-Selectin
1
2011
58
0.020
 Why?
Blood Transfusion
1
1994
324
0.020
 Why?
Heteroduplex Analysis
1
2011
1
0.020
 Why?
Pandemics
1
2020
1615
0.020
 Why?
Tuberculosis, Pulmonary
1
1993
142
0.020
 Why?
Antigens, CD
1
1994
524
0.020
 Why?
Chemokine CCL2
1
2011
117
0.020
 Why?
Hospitalization
1
2021
2183
0.020
 Why?
Hyperlipidemias
1
2011
120
0.020
 Why?
Cell Proliferation
2
2009
2471
0.020
 Why?
Fibrinogen
1
2011
170
0.020
 Why?
Protein Multimerization
1
2012
193
0.020
 Why?
Interferon-alpha
1
2012
198
0.020
 Why?
Nontuberculous Mycobacteria
1
1993
204
0.020
 Why?
Cell Adhesion Molecules
1
2011
183
0.020
 Why?
Cross Infection
1
1993
238
0.020
 Why?
Healthcare Disparities
1
2017
632
0.020
 Why?
Infant, Premature
1
1994
563
0.020
 Why?
Pokeweed Mitogens
1
2009
7
0.020
 Why?
L-Selectin
1
2009
26
0.020
 Why?
Diagnosis, Differential
1
2014
1484
0.020
 Why?
Human Experimentation
1
2009
13
0.020
 Why?
Tetanus
1
2009
25
0.020
 Why?
Candida
1
2009
37
0.020
 Why?
Leukocyte Common Antigens
1
2009
87
0.020
 Why?
Obesity
1
2021
2966
0.020
 Why?
Multivariate Analysis
1
2011
1524
0.020
 Why?
Meningitis, Aseptic
1
2007
13
0.020
 Why?
Virus Cultivation
1
2007
29
0.020
 Why?
Interleukin-6
1
2011
771
0.020
 Why?
Phosphorylation
1
2012
1762
0.020
 Why?
Data Interpretation, Statistical
1
2009
352
0.020
 Why?
Pregnancy Outcome
1
2010
410
0.020
 Why?
Cerebrospinal Fluid
1
2007
94
0.020
 Why?
Paralysis
1
2007
70
0.020
 Why?
Multiple Organ Failure
1
2007
127
0.020
 Why?
B-Lymphocytes
1
2012
844
0.020
 Why?
Kinetics
1
2010
1679
0.020
 Why?
Respiratory System
1
2007
158
0.020
 Why?
Genotype
1
2011
1906
0.020
 Why?
Immunoglobulin A, Secretory
1
2005
9
0.020
 Why?
Cell Survival
1
2009
1122
0.020
 Why?
Phosphates
1
1987
184
0.020
 Why?
Muscles
1
1987
325
0.020
 Why?
Encephalitis
1
2007
136
0.020
 Why?
Gastrointestinal Tract
1
2007
194
0.010
 Why?
Mucous Membrane
1
2005
125
0.010
 Why?
Chemistry, Physical
1
1984
38
0.010
 Why?
Antigen-Antibody Reactions
1
1984
55
0.010
 Why?
Chemical Phenomena
1
1984
85
0.010
 Why?
Myasthenia Gravis
1
1984
23
0.010
 Why?
DNA-Binding Proteins
1
2012
1502
0.010
 Why?
Immunologic Deficiency Syndromes
1
1984
68
0.010
 Why?
Tissue Distribution
1
1984
330
0.010
 Why?
Saliva
1
2005
242
0.010
 Why?
Tomography, X-Ray Computed
1
2014
2670
0.010
 Why?
Aging
2
2003
1863
0.010
 Why?
Blood Glucose
1
2013
2161
0.010
 Why?
Epithelium
1
1984
315
0.010
 Why?
Body Mass Index
1
2011
2351
0.010
 Why?
Middle Aged
2
2020
33118
0.010
 Why?
Infusions, Intravenous
1
2003
411
0.010
 Why?
Anti-Bacterial Agents
1
1993
1790
0.010
 Why?
Reference Values
1
2003
820
0.010
 Why?
Mice, Inbred BALB C
1
1984
1271
0.010
 Why?
Suspensions
1
2000
37
0.010
 Why?
Capsules
1
2000
42
0.010
 Why?
Urban Population
1
2003
470
0.010
 Why?
Drug Tolerance
1
2000
105
0.010
 Why?
Cytomegalovirus
1
2000
160
0.010
 Why?
Signal Transduction
1
2012
5077
0.010
 Why?
Administration, Oral
1
2000
811
0.010
 Why?
Epithelial Cells
1
1984
1097
0.010
 Why?
Immunization
1
2000
414
0.010
 Why?
Time Factors
1
2008
6802
0.010
 Why?
Macrophages
1
1984
1547
0.010
 Why?
Recombinant Proteins
1
2000
1357
0.010
 Why?
Tail
1
1987
28
0.000
 Why?
Mice
1
1984
17775
0.000
 Why?
Phosphocreatine
1
1987
47
0.000
 Why?
Salamandridae
1
1987
27
0.000
 Why?
Animals
2
1987
36915
0.000
 Why?
Aged
1
1984
23641
0.000
 Why?
Adenosine Triphosphate
1
1987
487
0.000
 Why?
Magnetic Resonance Spectroscopy
1
1987
616
0.000
 Why?
McFarland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (381) concept(s)
_
Co-Authors Expand Description
See all (18) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)